Antitumor activity against human IGROV1 cells xenografted in NCR SCID mouse assessed as tumor growth at 95 mg/kg, iv treated once daily for 4 days per...

Basic Information

ID: ALA4309314

Type: Functional

Description: Antitumor activity against human IGROV1 cells xenografted in NCR SCID mouse assessed as tumor growth at 95 mg/kg, iv treated once daily for 4 days per week for 4 weeks starting from 3 days post implantation and measured at day 60 post last dose relative to control

Format: BAO_0000218

Organism: Homo sapiens

Cell type: IGROV-1

Target:  IGROV-1(ALA613984)

Document:  ALA4308835

Antitumor activity against human IGROV1 cells xenografted in NCR SCID mouse assessed as tumor growth at 95 mg/kg, iv treated once daily for 4 days per week for 4 weeks starting from 3 days post implantation and measured at day 60 post last dose relative to control: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
479.491.651.65